HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF (Q24329023)

GOA release 2020-03-11

placental growth factor

1 reference

positive regulation of cell population proliferation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Mieke Dewerchin

0 references

Inmaculada Segura

Inmaculada Segura

0 references

Uwe Himmelreich

Uwe Himmelreich

0 references

Charlotte Rolny

Charlotte Rolny

0 references

Mario Leonardo Squadrito

Mario Leonardo Squadrito

0 references

Mia Phillipson

0 references

Sandra Costa

0 references

Massimiliano Mazzone

0 references

Peter Carmeliet

0 references

Michele De Palma

Michele De Palma

0 references

Lena Claesson-Welsh

Lena Claesson-Welsh

0 references

Sonia Tugues

Sònia Tugues

0 references

Stefan Vinckier

Stefan Vinckier

0 references

author name string

Damya Laoui

0 references

Irja Johansson

0 references

Cathy Coulon

0 references

Xiujuan Li

0 references

Ellen Knevels

0 references

Tom Dresselaer

0 references

Peter Åkerud

0 references

Maria De Mol

0 references

Henriikka Salomäki

0 references

Sabine Wyns

0 references

Erik Larsson

0 references

Ian Buysschaert

0 references

Johan Botling

0 references

Jo A Van Ginderachter

Colon carcinoma cell interaction with liver sinusoidal endothelium inhibits organ-specific antitumor immunity through interleukin-1-induced mannose receptor in mice

0 references

language of work or name

English

0 references

publication date

18 January 2011

0 references

0 references

0 references

0 references

31-44

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Macrophage diversity enhances tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Modes of resistance to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Murine histidine-rich glycoprotein: cloning, characterization and cellular origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein binds to cell-surface heparan sulfate via its N-terminal domain following Zn2+ chelation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Influence of applied volume on efficacy of 3-minute surgical reference disinfection method prEN 12791

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via Fc RI on phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021

Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2010.11.009

7 January 2021